Cargando…
Correlation of Interleukin-33/ST2 Receptor and Liver Fibrosis Progression in Biliary Atresia Patients
Background/Aims: Biliary Atresia (BA) is a devastating pediatric liver disease and characterized by aggressive liver fibrosis progression. The Interleukin-33 (IL-33)/ST2 receptor signaling axis has been demonstrated to be involved in several autoimmune and liver diseases. Since immune dysregulation...
Autores principales: | Liu, Jia, Yang, YiFan, Zheng, Chao, Chen, Gong, Shen, Zhen, Zheng, Shan, Dong, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781650/ https://www.ncbi.nlm.nih.gov/pubmed/31632941 http://dx.doi.org/10.3389/fped.2019.00403 |
Ejemplares similares
-
YAP Activation and Implications in Patients and a Mouse Model of Biliary Atresia
por: Zheng, Chao, et al.
Publicado: (2021) -
Evaluation of Perioperative Complications in the Management of Biliary Atresia
por: Du, Min, et al.
Publicado: (2020) -
Low gamma-glutamyl transpeptidase levels at presentation are associated with severity of liver illness and poor outcome in biliary atresia
por: Sun, Song, et al.
Publicado: (2022) -
Characteristics of the Gut Microbiome and IL-13/TGF-β1 Mediated Fibrosis in Post-Kasai Cholangitis of Biliary Atresia
por: Meng, Lingdu, et al.
Publicado: (2021) -
Forkhead box A3 attenuated the progression of fibrosis in a rat model of biliary atresia
por: Dong, Rui, et al.
Publicado: (2017)